Organ transplantation is the most effective treatment for end-stage organ failure, and its long-term efficacy is directly influenced by the level of post-operative medication management. Studies have shown a high incidence of medication errors and medication-related problems among solid organ transplant recipients, which can significantly increase the risk of acute rejection and reduce graft survival. Clinical transplant pharmacists play a crucial role in promoting rational medication use and improving recipient outcomes. Currently, pharmaceutical care for solid organ transplantation in China is still in its early stages, lacking unified service standards and practical guidelines. To address this, we organized a national panel of medical and pharmaceutical experts in the field of organ transplantation. Based on the latest international advances and evidence-based findings, and through extensive solicitation of opinions using a modified Delphi method, we developed the Chinese Expert Consensus on Pharmaceutical Care for Solid Organ Transplant Recipients. This consensus centers on the entire process—pre-transplant, perioperative, and post-transplant—and puts forward 12 recommendations. It aims to systematically establish a standardized pharmaceutical care model, provide practical guidance for clinical pharmacists and transplant physicians, and ultimately enhance the long-term quality of life and graft survival rates for solid organ transplant recipients in China.